Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 2, 2024
Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases
Lu Wang, Yusheng Lin, Zhimeng Yao, et al.
Pharmaceutics
|
May 4, 2026
A Novel Hypothermic Preservation Formulation Containing SUL-138 Enables Long-Term Hypothermic Storage of Clinical-Grade CAR-T Cells
Aysenur Öner, Nina Nooteboom, Linette Oosting, et al.
Gastroenterology
|
July 3, 2023
Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study
Kai Li, Yusheng Lin, Yu Zhou, et al.
Cancers
|
April 23, 2022
Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
Joyce M Lubbers, Marta A Ważyńska, Nienke van Rooij, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
A universal platform for simultaneous TCRα/β removal enables safer and more potent TCR therapies and autoimmune modeling
Giorgia Zanetti, Mateusz Legut, Austin Chen, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 21, 2024
Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage
Nienke Visser, Laure C M Herreman, Jennifer Vandooren, et al.
Molecular Cancer Therapeutics
|
January 24, 2026
DSP502 combines dual inhibition of PD-L1 and PVR to trigger anti-cancer immune responses
Vinicio A Melo Gallegos, Shirley Greenwald, Ami Tamir, et al.
Journal of Translational Medicine
|
January 16, 2026
Multi-omic profiling and preclinical efficacy of fratricide-driven, unedited CD7 CAR-T cells in T-cell leukemia
Jimena Álvarez Freile, Lena Rockstein, Rianne Kloosterman, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2022
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity
Ewa Cendrowicz, Lisa Jacob, Shirley Greenwald, et al.
Oncotarget
|
September 22, 2016
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
Fenne L Komdeur, Maartje C A Wouters, Hagma H Workel, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 2, 2024
Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases
Lu Wang, Yusheng Lin, Zhimeng Yao, et al.
Pharmaceutics
|
May 4, 2026
A Novel Hypothermic Preservation Formulation Containing SUL-138 Enables Long-Term Hypothermic Storage of Clinical-Grade CAR-T Cells
Aysenur Öner, Nina Nooteboom, Linette Oosting, et al.
Gastroenterology
|
July 3, 2023
Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study
Kai Li, Yusheng Lin, Yu Zhou, et al.
Cancers
|
April 23, 2022
Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
Joyce M Lubbers, Marta A Ważyńska, Nienke van Rooij, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
A universal platform for simultaneous TCRα/β removal enables safer and more potent TCR therapies and autoimmune modeling
Giorgia Zanetti, Mateusz Legut, Austin Chen, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 21, 2024
Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage
Nienke Visser, Laure C M Herreman, Jennifer Vandooren, et al.
Molecular Cancer Therapeutics
|
January 24, 2026
DSP502 combines dual inhibition of PD-L1 and PVR to trigger anti-cancer immune responses
Vinicio A Melo Gallegos, Shirley Greenwald, Ami Tamir, et al.
Journal of Translational Medicine
|
January 16, 2026
Multi-omic profiling and preclinical efficacy of fratricide-driven, unedited CD7 CAR-T cells in T-cell leukemia
Jimena Álvarez Freile, Lena Rockstein, Rianne Kloosterman, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2022
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity
Ewa Cendrowicz, Lisa Jacob, Shirley Greenwald, et al.
Oncotarget
|
September 22, 2016
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
Fenne L Komdeur, Maartje C A Wouters, Hagma H Workel, et al.
Page
of 10